Invention Grant
- Patent Title: Use of pimobendan for the reduction of heart size in mammals suffering from heart failure
-
Application No.: US15865339Application Date: 2018-01-09
-
Publication No.: US10537588B2Publication Date: 2020-01-21
- Inventor: Juergen Daemmgen , Olaf Joens , Rainer Kleemann
- Applicant: Boehringer Ingelheim Vetmedica GmbH
- Agent Judy Jarecki-Black
- Priority: EP04007179 20040325
- Main IPC: A61K31/50
- IPC: A61K31/50 ; A61K31/501 ; A61K31/44 ; A61K31/444 ; A61K31/4166 ; A61P9/04 ; A61P9/08 ; A61K31/7048 ; A61K31/4412 ; A61K31/4427 ; A61K31/341 ; A61K31/40 ; A61K45/06
Abstract:
A phosphodiesterase type III (PDE III) inhibitor or Ca2+-sensitizing agent or a pharmaceutically acceptable derivative thereof is provided for the preparation of a medication for the reduction of the heart size of a patient suffering from heart failure.
Public/Granted literature
- US20180185402A1 USE OF PDE III INHIBITORS FOR THE REDUCTION OF HEART SIZE IN MAMMALS SUFFERING FROM HEART DISEASE Public/Granted day:2018-07-05
Information query
